Skip to main content

Advertisement

Table 2 Kidney-related Outcomes

From: Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey

Characteristics TSC-AML Patient Age < = 18 (N = 31) TSC-AML Patient Age > 18 (N = 79) Total TSC-AML Patients (N = 110)
Embolization (e.g., for kidney lesions) 2 (7%) 23 (29%) 25 (23%)
Nephrectomy (kidney removal) 2 (7%) 12 (15%) 14 (13%)
Kidney transplant 0 (0%) 13 (17%) 13 (12%)
Had impaired kidney function 4 (13%) 39 (49%) 43 (39%)
Had high blood pressure/hypertension 3 (10%) 35 (44%) 38 (35%)
Had chronic kidney disease 4 (13%) 30 (38%) 34 (31%)
Had kidney failure 0 (0%) 23 (29%) 23 (21%)
On dialysis 0 (0%) 17 (22%) 17 (16%)
AML tumor involvement
 In both kidneys 26 (84%) 60 (76%) 86 (78%)
 Only in one kidney 5 (16%) 19 (24%) 24 (22%)
  Multiple tumors 3 (60%) 4 (21%) 7 (29%)
  Only one tumor 2 (40%) 15 (79%) 17 (71%)
  1. AML Angiomyolipoma, TSC Tuberous sclerosis complex